Lung Cancer Screening Eligibility Assessment
Using a Simplified Tool to Predict Lung Cancer Screening (LCS) Eligibility: Experiment to Test Effects of Messaging on Response Rates
3 other identifiers
interventional
6,125
1 country
1
Brief Summary
The primary purpose of this study evaluate if different messaging impacts response rates to a brief survey (i.e., the simplified eligibility tool) that is designed to estimate pack-year eligibility for lung cancer screening (LCS). This will help inform the best way to increase response rates to the tool in future intervention studies designed to increase LCS, and expand upon survey methodology in general.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable lung-cancer
Started Jul 2023
Shorter than P25 for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 31, 2023
CompletedFirst Submitted
Initial submission to the registry
October 18, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedResults Posted
Study results publicly available
May 31, 2025
CompletedMay 31, 2025
May 1, 2025
6 months
October 18, 2023
May 28, 2025
May 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Full Survey Completion
The proportion of participants that answers all three survey questions via text message among all those randomized.
7 days
Secondary Outcomes (1)
Partial Survey Completion
7 days
Study Arms (12)
Arm 1 (Introductory Message A + Tobacco Use Message A + Incentive)
EXPERIMENTALParticipants will receive two framed messages (AA) plus an incentive
Arm 2 (Introductory Message A + Tobacco Use Message A)
EXPERIMENTALParticipants will receive two framed messages (AA)
Arm 3 (Introductory Message A + Tobacco Use Message B + Incentive)
EXPERIMENTALParticipants will receive two framed messages (AB) plus an incentive
Arm 4 (Introductory Message A + Tobacco Use Message B)
EXPERIMENTALParticipants will receive two framed messages (AB)
Arm 5 (Introductory Message B + Tobacco Use Message A + Incentive)
EXPERIMENTALParticipants will receive two framed messages (BA) plus an incentive
Arm 6 (Introductory Message B + Tobacco Use Message A)
EXPERIMENTALParticipants will receive two framed messages (BA)
Arm 7 (Introductory Message B + Tobacco Use Message B + Incentive)
EXPERIMENTALParticipants will receive two framed messages (BB) plus an incentive
Arm 8 (Introductory Message B + Tobacco Use Message B)
EXPERIMENTALParticipants will receive two framed messages (BB)
Arm 9 (Introductory Message C + Tobacco Use Message A + Incentive)
EXPERIMENTALParticipants will receive two framed messages (CA) plus an incentive
Arm 10 (Introductory Message C + Tobacco Use Message A)
EXPERIMENTALParticipants will receive two framed message (CA)
Arm 11 (Introductory Message C + Tobacco Use Message B + Incentive)
EXPERIMENTALParticipants will receive two framed messages (CB) plus an incentive
Arm 12 (Introductory Message C + Tobacco Use Message B)
EXPERIMENTALParticipants will receive two framed messages (CB)
Interventions
Randomly assign patients to receive introductory message encouraging them to complete the survey (version A).
Randomly assign patients to receive introductory message encouraging them to complete the survey (version B).
Randomly assign patients to receive introductory message encouraging them to complete the survey (version C).
Randomly assign patients to receive norming message related to tobacco use (version A).
Randomly assign patients to receive norming message related to tobacco use (version B).
Randomly assigned patients to be entered into a drawing to receive a $100 gift card.
Eligibility Criteria
You may qualify if:
- meet age eligibility (50-80 years old) for LCS based on 2021 USPSTF guidelines; and
- have completed at least one primary care visit at Penn Medicine in 2020-2025
You may not qualify if:
- have a documented history of lung cancer;
- have a documented history of completing LCS at Penn Medicine;
- are listed as not wanting to be contacted or solicited for research; or
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abramson Cancer Center at Penn Medicinelead
- National Institutes of Health (NIH)collaborator
- National Cancer Institute (NCI)collaborator
Study Sites (1)
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Katharine Rendle, PI
- Organization
- University of Pennslyvania
Study Officials
- PRINCIPAL INVESTIGATOR
Katharine A Rendle, PhD,MSW,MPH
University of Pennsylvania
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 18, 2023
First Posted
November 18, 2023
Study Start
July 31, 2023
Primary Completion
January 31, 2024
Study Completion
January 31, 2024
Last Updated
May 31, 2025
Results First Posted
May 31, 2025
Record last verified: 2025-05